The Share Health Study: Teen Social Connections and Health (Phase 2)

NACompletedINTERVENTIONAL
Enrollment

1,099

Participants

Timeline

Start Date

February 5, 2019

Primary Completion Date

July 31, 2019

Study Completion Date

June 30, 2021

Conditions
Contraception
Interventions
BEHAVIORAL

SpeakOut

"SpeakOut aims to increase social communication about contraception between adolescent IUD and implant users and their peers. SpeakOut has four components:~1. Coaching session. Research staff will deliver a script to encourage recipients to share information about their contraceptive method with peers.~2. Digital materials for recipients to keep and/or share with friends.~3. Websites with information and resources. Staff will refer recipients to a website, either SpeakOutIUD.org or SpeakOutImplant.org, which contain information about their method.~4. Text messages with information about recipients' method and about how to share their experience. Recipients will be given the opportunity to sign up for text messages that will be sent for 8 weeks following receipt of SpeakOut."

BEHAVIORAL

PartyWise

The active comparator intervention is an alcohol assessment and education intervention using an SBIRT (Screening, Brief Intervention, and Referral to Treatment) framework. Staff will ask two screening questions developed by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the American Academy of Pediatrics to screen for adolescents potentially at risk. Using a script based on tenets of motivational interviewing to assess alcohol related consequences, the staff will guide teens in identifying personally relevant motivators for healthier behaviors, assess readiness to change, and offer educational materials and referrals.

Trial Locations (1)

94118

Kathleen Tebb, San Francisco

All Listed Sponsors
collaborator

University of California, Davis

OTHER

lead

University of California, San Francisco

OTHER

NCT03842540 - The Share Health Study: Teen Social Connections and Health (Phase 2) | Biotech Hunter | Biotech Hunter